日本橋れいわ内科クリニック

受賞

• 日本学術振興会特別研究員DC1

著書

• 医療に必ず役立つiPhone/iPad　株式会社羊土社（平成24年）

特許

• 特許6330966　発明の名称：インスリン投与量調整装置およびインスリン投与量調整方法

論文

• Iuchi H, et al. Time-dependent effects of ipragliflozin on behaviour and energy homeostasis in normal and type 2 diabetic rats: continuous glucose telemetry analysis. Sci Rep. 2017;7(1):11906.
• Iuchi H, et al. Association between day-by-day and ambulatory blood pressure variability in type 2 diabetes patients. Blood Press Monit. 2017;22(6):351-354.
• Iuchi H, et al. The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial. Diabetes Technol Ther. 2017;19(8):457-462.
• Iuchi H, et al. Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes. PLoS One. 2016;11(1):e0144921.

招待講演

• 第61回日本糖尿病学会　シンポジウム9 SGLT2阻害薬の臨床的役割とメカニズム

受賞

• WILEY Top Cited Article 2022-2023
• WILEY Top Downloaded Article
• 日本抗加齢医学会 若手研究者賞
• 東京都医師会 医学研究賞奨励賞
• 日本糖尿病学会年次学術集会 若手研究奨励賞（YIA）
• 日本ホルモンステーション Clinical Investigator Award

論文

• Sasaki H, et al. Progression from isolated posterior pituitary dysfunction to combined anterior hormone deficiencies with pituitary stalk enlargement in suspected lymphocytic hypophysitis: a case report. Cureus. 2025;17(12):e98595.
• Sasaki H, et al. Severe metformin-associated lactic acidosis managed without dialysis in an elderly patient with multiple comorbidities: a case report. Cureus. 2025;17(8):e89686.
• Sasaki H, et al. Efficacy and safety of a continuous intravenous insulin protocol modified for East Asians in postoperative glycemic management following pancreatectomy. Cureus. 2025;17(5):e84527.
• Sasaki H, et al. Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism? Diabetes Metab. 2022;48(4):101338.
• Sasaki H, et al. Dipeptidyl peptidase-4 inhibitors and beta cell mass in Japanese adults with type 2 diabetes. Endocr Pract. 2022;28(5):563-564.
• Sasaki H, et al. Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: a case report. J Diabetes Investig. 2022;13(6):1105-1108.
• Sasaki H, et al. Revisiting regulators of human β-cell mass to achieve β-cell-centric approach toward type 2 diabetes. J Endocr Soc. 2021;5(10):bvab128.
• Sasaki H, et al. Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes. Diabetologia. 2021;64(8):1816-1821.
• Sasaki H, et al. Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults. Diabetologia. 2020;63(6):1199-1210.